- AMTD Digital (HKD) +80%.
- NovoCure (NVCR) +73% announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint.
- Oblong (OBLG) +42%.
- Argo Blockchain (ARBK) +34%.
- Zai Lab (ZLAB) +33% Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint.
- Addentax Group (ATXG) +20%.
- AMTD IDEA (AMTD) +21%.
- Magic Empire Global (MEGL) +17%.
- Huadi International Group (HUDI) +13%.
- Genprex (GNPX) +11% signs exclusive license to additional diabetes technology with the university of Pittsburgh
- JanOne (JAN) +11%.
- Kala Pharmaceuticals (KALA) +10%.
- Akili (AKLI) +8%.
- Intelligent Living Application Group (ILAG) +9%.
- DBV Technologies (DBVT) +9%.
- CytomX Therapeutics (CTMX) +8%.
- I-Mab (IMAB) +7%.
- Kiora Pharmaceuticals (KPRX) +6%.
- Kingsoft Cloud (KC) +5%.